Presenilin 1(Phospho Ser357) Polyclonal Antibody

Alzheimer's disease (AD) patients with an inherited form of the disease carry mutations in the presenilin proteins (PSEN1; PSEN2) or in the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid-beta (main component of amyloid deposits found in AD brains). Presenilins are postulated to regulate APP processing through their effects on gamma-secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor, such that they either directly regulate gamma-secretase activity or themselves are protease enzymes. Several alternatively spliced transcript variants encoding different isoforms have been identified for this gene, the full-length nature of only some have been determined.

Introducing the Presenilin-1 Phospho-Ser357 Polyclonal Antibody, meticulously developed by BT Lab, a renowned name in the field of biotechnology. This cutting-edge antibody is designed to specifically target and detect the phosphorylated form of Presenilin-1 at serine 357 residue, enabling researchers to delve deeper into the intricate mechanisms underlying neurodegenerative disorders.

Crafted with utmost precision and utilizing state-of-the-art techniques, this polyclonal antibody exhibits exceptional sensitivity and specificity, ensuring accurate and reliable results. Its affinity towards the phosphorylated Presenilin-1 epitope guarantees minimal cross-reactivity, thereby enhancing the credibility of experimental outcomes.

The Presenilin-1 Phospho-Ser357 Polyclonal Antibody is an invaluable tool for researchers investigating the role of Presenilin-1 in various cellular processes, particularly those associated with Alzheimer's disease and other related pathologies. By selectively targeting the phosphorylated form of Presenilin-1, this antibody enables the elucidation of intricate signaling pathways and molecular interactions, shedding light on the underlying molecular mechanisms.

With its robust performance and exceptional reproducibility, this antibody is suitable for a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence. Its versatility allows for seamless integration into diverse experimental setups, facilitating comprehensive investigations into Presenilin-1 biology.

Furthermore, the Presenilin-1 Phospho-Ser357 Polyclonal Antibody is meticulously validated through rigorous quality control measures, ensuring consistent and reliable performance. Each batch undergoes meticulous testing to guarantee optimal specificity, sensitivity, and reproducibility, providing researchers with the utmost confidence in their experimental results.

In summary, the Presenilin-1 Phospho-Ser357 Polyclonal Antibody by BT Lab is a cutting-edge research tool that empowers scientists to unravel the intricate molecular mechanisms underlying neurodegenerative disorders. With its exceptional sensitivity, specificity, and versatility, this antibody is poised to revolutionize research in the field, offering unprecedented insights into Presenilin-1 biology.